Algeta to Participate in Upcoming Investor Conference

April 17, 2013

OSLO, NORWAY--(Marketwired - Apr 17, 2013) - Algeta ASA ( OSE : ALGETA ), a company focused on the development of novel targeted cancer therapeutics, announces that members of its senior management and IR teams will participate in the following investor conference:

Kempen & Co. 6(th) Healthcare/Life Sciences Conference

Date: 23 April 2013

Participants:

Thomas Ramdahl (Chief Technology Officer)

Renate Birkeli (IR)

Venue: Amsterdam, The Netherlands

About Algeta

Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (ALGETA.OL). For more information please visit www.algeta.com.

Algeta to Participate in Upcoming Investor Conference:

http://hugin.info/134655/R/1693399/556601.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE

[HUG#1693399]